Health Canada Approves SIMPONI(TM) (golimumab) For Treatment Of Rheumatoid Arthritis, Psoriatic Arthritis And Ankylosing Spondylitis

Podiatry Arena Health Canada Approves SIMPONI(TM) (golimumab) For Treatment Of Rheumatoid Arthritis, Psoriatic Arthritis And Ankylosing Spondylitis

Welcome to the Podiatry Arena forums, for communication between foot health professionals about podiatry and related topics.

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members (PM), upload content, view attachments, receive a weekly email update of new discussions, earn CPD points and access many other special features. Registered users do not get displayed the advertisments in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

If you have any problems with the registration process or your account login, please contact contact us.

Health Canada Approves SIMPONI(TM) (golimumab) For Treatment Of Rheumatoid Arthritis, Psoriatic Arthritis And Ankylosing Spondylitis

Submit Thread >

< Submit Thread

Thread Tools

Display Modes

17th April 2009, 09:10 AM

RSSFeedBot RSSFeedBot is offline

I, Robot

About:

Join Date: Jul 2008

Posts: 10,133

Join Date: Jul 2008

Marketplace reputation 0% (0)

CPD Points: 1

Thanks: 0

Thanked 22 Times in 22 Posts

Health Canada Approves SIMPONI(TM) (golimumab) For Treatment Of Rheumatoid Arthritis, Psoriatic Arthritis And Ankylosing Spondylitis

Podiatry Arena members do not see these ads

Centocor Ortho Biotech Inc. and Schering-Plough Corporation (NYSE: SGP) announced that Health Canada has granted approval of SIMPONI (TM) (golimumab) as a once-monthly, subcutaneous therapy for the treatment of moderately to severely active rheumatoid arthritis (RA), active psoriatic arthritis (PsA) and active ankylosing spondylitis (AS).

More...

Sponsored Links

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Switch to Linear Mode Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts	vB code is On Smilies are On [IMG] code is On HTML code is On

Forum Jump

Translate This Page

Similar Threads

Thread	Thread Starter	Forum	Replies	Last Post
Ustekinumab In The Treatment Of Psoriatic Arthritis: Investigational Study Published	RSSFeedBot	Latest Rheumatology News	0	16th March 2009 03:30 PM
Psoriatic Arthritis Treatment of Ustekinumab Effective, Study Suggests	RSSFeedBot	Latest Rheumatology News	0	11th February 2009 10:51 PM
Study Shows ENBREL(R) (etanercept) More Effective Than A DMARD In The Treatment Of Symptoms Of Ankylosing Spondylitis Patients	RSSFeedBot	Latest Rheumatology News	0	27th October 2008 06:30 AM
Psoriatic Arthritis: First International Guidelines For Treatment	RSSFeedBot	Latest Rheumatology News	0	27th October 2008 05:22 AM
First International Guidelines For Treatment Of Psoriatic Arthritis Developed	RSSFeedBot	Latest Rheumatology News	0	26th October 2008 09:00 PM

New To Site?	Need Help?
Register to Participate View Forum Leaders Contact Us	Frequently Asked Questions Did you forget your password? Mark Forums Read

Finding your way around:

Browse the forums.

Search the site.

Browse the tags.

Search the tags.

All times are GMT -7. The time now is 02:48 PM.

User Name		Remember Me?
Password